SEC Form 4 · accession 0001562180-18-001326
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Silji Abraham
Officer — Chief Digital & Trans Officer
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 5:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 26, 2018 | A | 4,638 | $0.00 | A | 4,638 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F2 | $86.24 | Feb 26, 2018 | A | 10,520 | A | Feb 26, 2019 | Feb 26, 2028 | Common Stock | 10,520 | 10,520 | D |
Explanation of responses
- F1This award vests over 3 years starting on the 1st anniversary date of the award.
- F2This award vests in 4 equal annual installments beginning on 2/26/2019.